Melief CJ - Search Results

1

The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.

Sette A, Vitiello A, Reherman B, Fowler P, Nayersina R, Kast WM, Melief CJ, Oseroff C, Yuan L, Ruppert J, Sidney J, del Guercio MF, Southwood S, Kubo RT, Chesnut RW, Grey HM, Chisari FV. Sette A, et al. Among authors: melief cj. J Immunol. 1994 Dec 15;153(12):5586-92. J Immunol. 1994. PMID: 7527444

2

Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins.

Kast WM, Brandt RM, Sidney J, Drijfhout JW, Kubo RT, Grey HM, Melief CJ, Sette A. Kast WM, et al. Among authors: melief cj. J Immunol. 1994 Apr 15;152(8):3904-12. J Immunol. 1994. PMID: 7511661

3

Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.

Ressing ME, Sette A, Brandt RM, Ruppert J, Wentworth PA, Hartman M, Oseroff C, Grey HM, Melief CJ, Kast WM. Ressing ME, et al. Among authors: melief cj. J Immunol. 1995 Jun 1;154(11):5934-43. J Immunol. 1995. PMID: 7538538

4

Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability.

van der Burg SH, Visseren MJ, Brandt RM, Kast WM, Melief CJ. van der Burg SH, et al. Among authors: melief cj. J Immunol. 1996 May 1;156(9):3308-14. J Immunol. 1996. PMID: 8617954

5

Cytotoxic T lymphocytes against the antigen-processing-defective RMA-S tumor cell line.

Sijts AJ, De Bruijn ML, Nieland JD, Kast WM, Melief CJ. Sijts AJ, et al. Among authors: melief cj. Eur J Immunol. 1992 Jun;22(6):1639-42. doi: 10.1002/eji.1830220644. Eur J Immunol. 1992. PMID: 1601045

6

T-cell immunotherapy of cancer.

Melief CJ, Kast WM. Melief CJ, et al. Res Immunol. 1991 Jun-Aug;142(5-6):425-9. doi: 10.1016/0923-2494(91)90042-h. Res Immunol. 1991. PMID: 1754715 Review.

7

In vivo efficacy of virus-derived peptides and virus-specific cytotoxic T lymphocytes.

Kast WM, Melief CJ. Kast WM, et al. Among authors: melief cj. Immunol Lett. 1991 Oct;30(2):229-32. doi: 10.1016/0165-2478(91)90030-e. Immunol Lett. 1991. PMID: 1757108 Review.

8

Cytotoxic T lymphocyte therapy of cancer and tumor escape mechanisms.

Melief CJ, Kast WM. Melief CJ, et al. Semin Cancer Biol. 1991 Oct;2(5):347-54. Semin Cancer Biol. 1991. PMID: 1773050 Review.

9

Fine peptide specificity of cytotoxic T lymphocytes directed against adenovirus-induced tumours and peptide-MHC binding.

Kast WM, Melief CJ. Kast WM, et al. Among authors: melief cj. Int J Cancer Suppl. 1991;6:90-4. doi: 10.1002/ijc.2910470718. Int J Cancer Suppl. 1991. PMID: 2066186

10

Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells.

Kast WM, Boog CJ, Roep BO, Voordouw AC, Melief CJ. Kast WM, et al. Among authors: melief cj. J Immunol. 1988 May 1;140(9):3186-93. J Immunol. 1988. PMID: 2834454

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

543 results

Search Page

Filters